Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma

Table 1 Expression of paxillin protein categorized by pathological variables.

Variables	Paxillin		P
	-	+
Serum AFP level
≤25 ng/mL (n = 22)	13	9	0.604
>25 ng/mL (n = 29)	15	14
HBsAg
Positive (n = 16)	8	8	0.638
Negative (n = 35)	20	15
Microsatellite nodule
Absent (n = 31)	17	14	0.991
Present (n = 20)	11	9
Tumor size
≤3 cm (n = 18)	8	10	0.272
>3 cm (n = 33)	20	13
Cirrhosis
Absent (n = 36)	20	16	0.886
Present (n = 15)	8	7
Necrosis
Absent (n = 24)	13	11	0.922
Present (n = 27)	15	12
Portal vein thrombosis
Absent (n = 37)	24	13	0.021
Present (n = 14)	4	10
Differentiation
Well (n = 35)	24	11	0.004
Low (n = 16)	4	12
Extra-hepatic metastasis
Absent (n = 41)	26	15	0.014
Present (n = 10)	2	8